Discovering the Next-Generation of GPCR-targeted Therapeutics to Address Metabolic Diseases with Unmet Patient Needs

Time: 10:00 am
day: Day Two AM


  • Leveraging a novel drug modality and proprietary discovery platform to unlock peptide & protein GPCRs
  • Advancing a pipeline of differentiated therapeutics for cardiometabolic and immunological diseases
  • Capturing the untapped potential of Class A and Class B GPCRs with novel therapeutic approaches and drug-conjugates